AI assistant
AbbVie Inc. — Director's Dealing 2014
Jul 2, 2014
29755_dirs_2014-07-02_97ba45b9-38d1-4d5c-95fe-519a318e1217.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: AbbVie Inc. (ABBV)
CIK: 0001551152
Period of Report: 2013-03-31
Reporting Person: LIDDY EDWARD M (Director)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2013-03-31 | Stock Equivalent Units | $0 | A | 846 | Acquired | Common stock (846) | Direct | |
| 2013-06-30 | Stock Equivalent Units | $0 | A | 834 | Acquired | Common stock (834) | Direct | |
| 2013-09-30 | Stock Equivalent Units | $0 | A | 771 | Acquired | Common stock (771) | Direct | |
| 2013-12-31 | Stock Equivalent Units | $0 | A | 653 | Acquired | Common stock (653) | Direct | |
| 2014-03-31 | Stock Equivalent Units | $0 | A | 671 | Acquired | Common stock (671) | Direct | |
| 2014-06-30 | Stock Equivalent Units | $0 | A | 611 | Acquired | Common stock (611) | Direct |
Footnotes
F1: Director fees credited to stock equivalent unit accounts established by the director at Abbott Laboratories and AbbVie. The stock equivalent units in the Abbott account will be paid, in cash, generally at age 65 or upon retirement from Abbott's board, and the stock equivalent units in the AbbVie account will be paid, in cash, generally at age 65 or upon retirement from AbbVie's board. The stock equivalent units in each account earn the same return as if the fees were invested in AbbVie stock.
F2: Balance includes stock equivalent units acquired pursuant to a dividend equivalent reinvestment feature.